Clinical trial

Canadian Multicenter Observational Study of Tysabri in Early Relapsing Remitting Multiple Sclerosis Participants

NCT01706107

Study summary

ClinicalTrials.gov

Canadian Multicenter Observational Study of Tysabri in Early Relapsing Remitting Multiple Sclerosis Participants

Design: OBSERVATIONAL · Status: TERMINATED · Phase: Not specified

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

0 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

No interventions are currently published for this study in CureCurrent. View the original registry record above.

StatusTERMINATED

Study typeOBSERVATIONAL

Start date2012-11-07

PhaseN/A

Conditions

Relapsing-Remitting Multiple Sclerosisverified · MONDO: relapsing-remitting multiple sclerosis

Interventions

Sponsors & collaborators

Biogenlead sponsor

Mapped research locations

MontrealQuebec, Canada2 TorontoOntario, Canada1 LondonOntario, Canada1 HalifaxNova Scotia, Canada1 SherbrookeQuebec, Canada1 VictoriaBritish Columbia, Canada1 Greenfield ParkQuebec, Canada1 GatineauQuebec, Canada1 Saint JohnNew Brunswick, Canada1 SydneyNova Scotia, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01706107 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.